both bilateral agreements and communication. Whereas reported care related issues related to challenges such as the assessment of care receivers' needs and the use of assistive devices in the provision of ADL-care. The inventoried challenges will be addressed in an ADL-quality standard for nursing staff. Home healthcare is a critical care source for communitydwelling older adults. As the fastest growing healthcare sector in the US, quality of home healthcare is under increasing scrutiny. The purpose of this study is to examine patterns of performance on quality of care among US home health agencies. This is a 3-year cohort study using 2015-2017 Home Health Compare data and Provider of Services (POS) Files. In the dataset, each HHA was assigned a star rating (1-5) to reflect the overall quality of care. This indicator was calculated based on two process measures (timely initiation of care and drug education) and six outcome measures (e.g., hospitalization). We examined 8,020 HHAs in the US. Over the 3-year period, the number of HHAs receiving a star rating of 4 or 5 increased from 27% in 2015, 31% in 2016, to 32% in 2017. Roughly, 32% of the HHAs received a lower star rating and another 32% received a higher star rating from 2015 to 2016. Similarly, 30% of the HHAs received a lower star rating and 29% of the HHAs received a higher star rating from 2016 to 2017. Hospital-based HHAs were less likely to receive a star rating of 4 or 5. Larger HHAs (OR 1.34; 95% CI, 1.13-1.59) and HHAs with ownership changes (OR, 1.38; 95% CI 1.20-1.59) were more likely to improve their star ratings overtime. Our finding indicates dynamic changes in the quality of care within the US home healthcare sector.
TRENDS IN HEALTHCARE COSTS AND UTILIZATION ASSOCIATED WITH HEARING LOSS DIAGNOSIS OVER 10 YEARS
Nicholas Reed, 1 Jennifer A. Deal, 2 Frank Lin, 1 and Charlotte Yeh 3 , 1. Johns Hopkins University, Baltimore, Maryland, United States, 2. Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States, 3. AARP Services, Inc., Washington, District of Columbia, United States Hearing loss affects 38 million Americans and is associated with cognitive and physical decline. Moreover, hearing loss limits communication between patients and providers. In this study, we aimed to determine whether hearing loss diagnosis impacts healthcare cost and utilization. In the OptumLabs Data Warehouse insurance claims database (January 1, 1999 to December 31, 2016) we identified cases of age-related hearing loss (i.e. excluding conductive, ototoxicinduced, surgical-related hearing losses) in adults over the age of 50 years. Hearing loss cases were propensity-matched (nearest neighbor) to persons without hearing loss on multiple socioeconomic (income, region), demographic (age, sex, race, education), and health status (comorbidity count, cancer, dementia, baseline resource utilization) indices. There were 154,414, 44,852, and 4,728 subjects, respectively, at the 2-, 5-, and 10-year follow-up time points. We used regression modeling to examine healthcare cost (total expenditures), inpatient hospitalization, length of inpatient stay, outpatient visits, 30-day readmissions, and emergency department visits. Among 4,728 matched adults, hearing loss was associated with $22,434 (95% CI $18,219-$26,648) or 46% higher total healthcare costs over a 10-year period compared to those without hearing loss. Persons with hearing loss experienced more inpatient stays (Incident Rate Ratio, 1.47; 95% CI 1.29-1.68) and were at-risk (44% higher risk) for greater 30-day hospital readmission (Relative Risk, 1.44; 95% CI 1.14-1.81) at 10-years post index date. Similar trends were observed at 2and 5-year time points across all measures. Importantly, these pathways may be amendable to hearing treatment via amplification which warrants future research preventative strategies. Greensboro, North Carolina, United States, 3. Duke University School of Medicine, Durham, North Carolina, United States, 4. Duke University Medical Center, Durham, North Carolina, United States Racial/ethnic differences in obesity prevalence and in responses to weight-loss treatment between Black and White women are well documented. Whether these differences influence responses to weight-loss treatment among older women is unknown. Therefore, we evaluated racial/ethnic differences among participants in a 6-month weight-loss study with traditional versus higher protein intake. Participants were obese (BMI ≥ 30 kg/m2) community-dwelling women, age 45 years or older, who self-identified as either Black or White. Change in body-weight, 6 minute walk test (6MWT), general health (SF-36), and satisfaction with life (SWL) were evaluated at 0, 4 and 6 months. Both racial groups reduced (ps < 0.01) body weight at 4 and 6 months, with a trend toward more weight loss among White women (p = 0.07), relative to Black women. Other racial/ethnic differences included greater improvements in general health (p = 0.05) and 6MWT (p < 0.05) for White versus Black women at 6 months; these differences persisted after adjusting for treatment group, age/education, and comorbidity. Although racial/ethnic differences in SWL were not observed, significant improvement was observed only among White women (p < 0.01). Interestingly, weight loss was associated with improved 6MWT only among Black women (r = -0.66, p < 0.05) and with general health only among White women (r = -0.44, p < 0.05). Overall, White women experienced greater improvements in health and physical function as a result of weight-loss than did Black women. Further research is needed to identify equitable intervention strategies for the treatment of sarcopenic obesity.
EXPLORING THE IMPACT OF RACE-ETHNICITY ON RESPONSE TO WEIGHT-LOSS TREATMENT: RESULTS FROM THE POWR-UP STUDY

